Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage.
about
Transition of research focus from vasospasm to early brain injury after subarachnoid hemorrhageThe importance of early brain injury after subarachnoid hemorrhageManagement of delayed cerebral ischemia after subarachnoid hemorrhageTo look beyond vasospasm in aneurysmal subarachnoid haemorrhage.Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injuryRapid aneurysm growth and rupture in systemic lupus erythematosusProtective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage.Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage.Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.Clinical trials in cardiac arrest and subarachnoid hemorrhage: lessons from the past and ideas for the future.Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions.Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic reviewProtective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhageControversies and evolving new mechanisms in subarachnoid hemorrhage.Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.SAH pituitary adrenal dysfunction.Endocrine function following acute SAH.New therapeutic approaches to subarachnoid hemorrhage.Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage.Delayed neurological deterioration after subarachnoid haemorrhage.Current management of delayed cerebral ischemia: update from results of recent clinical trials.Treatment of endocrine disorders in the neuroscience intensive care unit.The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage.Vasospasm in cerebral inflammation.An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage.Statins and anti-inflammatory therapies for subarachnoid hemorrhage.Impact of dexamethasone in patients with aneurysmal subarachnoid haemorrhage.Dehydroepiandrosterone sulphate: diabolical hormone or epiphenomenon in aneurysmal subarachnoid hemorrhage?Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage.The spectrum of management practices in nontraumatic subarachnoid hemorrhage: A survey of high-volume centers in the United States.The Role of Thromboinflammation in Delayed Cerebral Ischemia after Subarachnoid Hemorrhage.Cysteamine alleviates early brain injury via reducing oxidative stress and apoptosis in a rat experimental subarachnoid hemorrhage model.A Propensity Score-Matched Study of the Use of Non-steroidal Anti-inflammatory Agents Following Aneurysmal Subarachnoid Hemorrhage.Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage.Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage.
P2860
Q26825343-B76FC7EA-78D0-4FB9-9925-597AD4E83A24Q27028040-B0495B63-AB04-4591-9DE1-B9F0D5B6924DQ28076405-70CA7E88-C2D2-4F81-AD67-77D7BC33D196Q33747387-FF780755-BC33-4BF3-8DF8-09A3A6F32259Q34504672-B2939E7E-9406-4032-B690-1B7578221416Q35025422-F5F7C6E3-E2C7-404D-8F30-55C0418D6582Q35074224-3EF6DE69-C883-468B-A27C-27076CDAE143Q35108572-415C7661-FFD6-4E5E-9A4C-DFC8C7FDE7A2Q36230958-4D5E0E61-CE86-47D9-BF46-F8F5CDE4CFC0Q36711857-6924F1FA-2806-4293-B096-EB132460159DQ36831190-0ABD2369-1DC9-431A-8AB4-A8EE8461F9E0Q37019652-058F4D31-6142-4569-974F-017CC221B126Q37565685-2E871CBC-2352-44CF-BB8E-806051DF2FBBQ37652820-D6667EB1-4339-4C08-A01E-D41ABF97CE6AQ37902985-A05195EA-CCE5-4FFF-99A3-24E2A29FCFBAQ37907957-4FC8E548-6AA0-4E60-A877-173AC3B4E857Q37910051-768704E6-0B89-4AB9-8DDA-802FA6F64F28Q38005212-9C554B47-78AB-4F50-B25F-09764642FD40Q38166813-DDA78647-9990-445F-9669-E8D648047950Q38169976-411609E4-5323-484C-A733-9934C8BBFFB9Q38171354-35009279-CC9F-47C9-8F31-8E63BB306F91Q38175892-A72B2F10-6819-4B8E-8F84-44B217CC9010Q38213375-375A4AAC-BFC6-4E82-9D77-D8FF04EFBFE9Q38327987-2D01F447-87BD-4468-AA89-07789BE1349DQ38755733-14C22850-EF68-4674-847B-F3F391EF4F83Q39663927-48A16FB0-1344-4F2E-B6E4-8810665A7891Q40327476-BD72A594-ABEE-4AF5-A0ED-7F82530A62C7Q41236245-862D09DD-7454-477B-8C5F-01217AD206C8Q41958830-8092CD43-529D-4692-B9C5-53072677FC74Q42788333-8D95F5FA-CEB1-409F-9BF7-97DDB13AE46DQ43410409-E8CC3207-D433-4CFF-8253-B41BD2BFF373Q46796441-3EECB820-F8D5-40F2-9E8F-F9C5E5202330Q48820445-012152BC-9A12-4D8D-9E63-6422FF13B16CQ55024490-B666C02A-09F9-440A-AE79-694953F48714Q55362801-A81AB2E4-68A3-4232-90BD-BBE0D93FBB81
P2860
Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Randomized, double-blind, plac ...... ysmal subarachnoid hemorrhage.
@en
Randomized, double-blind, plac ...... ysmal subarachnoid hemorrhage.
@nl
type
label
Randomized, double-blind, plac ...... ysmal subarachnoid hemorrhage.
@en
Randomized, double-blind, plac ...... ysmal subarachnoid hemorrhage.
@nl
prefLabel
Randomized, double-blind, plac ...... ysmal subarachnoid hemorrhage.
@en
Randomized, double-blind, plac ...... ysmal subarachnoid hemorrhage.
@nl
P2093
P356
P1476
Randomized, double-blind, plac ...... ysmal subarachnoid hemorrhage.
@en
P2093
Bernard Scherpereel
Dominique Hettler
Jean Pierre Graftieaux
Pascal Rousseaux
Philippe Gomis
Richard Sercombe
P304
P356
10.3171/2009.4.JNS081377
P577
2010-03-01T00:00:00Z